Exco InTouch, a provider of patient communications products, has secured a £3 million investment that has been led by growth equity and venture capital group Scottish Equity Partners.
Growth investor Beaubridge has completed a second financing for Smilepod, a walk-in dental hygiene business, injecting £1.2 million to fund the rollout of more outlets.
Cambridge-based spin-out Mission Therapeutics has launched following completion of a £6 million Series A funding round led by venture capital firm Sofinnova Partners.
Biotechnology company Autifony Therapeutics has closed a £10 million financing, securing a £5 million investment each from Imperial Innovations and SV Life Sciences.
AIM-listed Allocate Software has made its second acquisition in two months with the purchase of Zircadian Holdings as part of a strategy to build its healthcare products range.
Stanmore Implants, a developer of orthopaedic implants, has secured £4 million in equity investment from Imperial Innovations Group as the company launches a new product in the US.
Allocate Software plans to build a bigger Australian presence with the acquisition of RosterOn, a provider of workforce management software to the healthcare market.
Venture capital firm Wellington Partners and Edmond de Rothschild Investment Partners have raised €13 million (£11.5 million) Series A financing round in medical device company Sapiens.
EFK Diagnostics (EFK), an AIM-listed manufacturer of healthcare equipment, has agreed to acquired the entire issued share capital of Stanbio Laboratory in a deal worth $25.5 million (£15.7 million).
